Translational Development Acquisition Corp. (TDAC)
NASDAQ: TDAC · Real-Time Price · USD
10.44
-0.01 (-0.10%)
Dec 5, 2025, 4:00 PM EST - Market closed
TDAC Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Selling, General & Admin | 0.92 | 0.2 | 0.49 | 0.07 |
| Operating Expenses | 0.92 | 0.2 | 0.49 | 0.07 |
| Operating Income | -0.92 | -0.2 | -0.49 | -0.07 |
| Interest & Investment Income | 5.8 | 0.13 | - | - |
| Pretax Income | 4.76 | -0.07 | -0.49 | -0.07 |
| Net Income | 4.76 | -0.07 | -0.49 | -0.07 |
| Net Income to Common | 4.76 | -0.07 | -0.49 | -0.07 |
| Shares Outstanding (Basic) | 18 | 4 | 4 | 4 |
| Shares Outstanding (Diluted) | 18 | 4 | 4 | 4 |
| Shares Change (YoY) | 339.15% | 8.46% | - | - |
| EPS (Basic) | 0.27 | -0.02 | -0.12 | -0.02 |
| EPS (Diluted) | 0.27 | -0.02 | -0.12 | -0.02 |
| EBIT | -0.92 | -0.2 | -0.49 | -0.07 |
Source: S&P Capital IQ. Standard template.
Financial Sources.